Loading: 100%
AEROJET ROCKETDYNE HOLDINGS, INC. logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 4,965 (as per Q2 2017)no data available
Sector Aerospace & Defense, IndustrialsAerospace & Defense, Industrialsno data available
Ticker AJRDno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 17010203040
datesClosing price (adj.)
13.10.201733.77
11.10.201734.85
04.10.201734.81
27.09.201735.16
20.09.201731.75
13.09.201728.11
06.09.201728.52
30.08.201729.19
23.08.201728.13
16.08.201727.32
09.08.201727.30
02.08.201723.53
26.07.201723.63
19.07.201722.83
12.07.201722.37
05.07.201721.89
27.06.201720.54
20.06.201720.73
13.06.201721.32
06.06.201721.30
30.05.201721.70
23.05.201721.35
16.05.201720.69
09.05.201721.10
02.05.201722.18
25.04.201723.18
18.04.201721.87
11.04.201721.75
04.04.201721.61
28.03.201721.58
21.03.201721.65
14.03.201721.88
07.03.201722.00
28.02.201719.39
21.02.201719.33
14.02.201719.24
07.02.201718.71
31.01.201718.11
24.01.201718.33
17.01.201717.85
10.01.201718.02
03.01.201718.41
27.12.201618.23
19.12.201618.00
12.12.201618.57
05.12.201620.75
28.11.201620.75
21.11.201620.58
14.11.201620.11
07.11.201616.41
31.10.201617.60
24.10.201616.84
17.10.201617.03
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
33.77n/a
Market Capitalisation
in million USD
2,536n/a
Enterprise Value
in million USD
0n/a
Common Shares Outstanding
as per Jul 31, 2017
75,100,000n/a
Preferred Shares Outstanding
as per Jul 31, 2017
n/a
Average Basic Shares Outstanding
TTM
70,375,000n/a
Average Diluted Shares Outstanding
TTM
70,475,000n/a
Index Membership
n/a
Business Summary
Aerojet Rocketdyne Holdings Inc manufactures aerospace and defense products and systems which develops and manufactures propulsion systems for defense and space applications, and armaments for precision tactical and long-range weapon systems applications.
no data available
Key Financials & Ratios (all figures TTM as per , million USD, full statements further below)
Profit & Loss
Revenues 0n/a
Gross Profit 0n/a
Operating Income 0n/a
EBITDA 0n/a
Net Profit 0n/a
Balance Sheet
Cash and Cash Equivalents 0n/a
Receivables 0n/a
Total Current Assets 0n/a
PP&E 0n/a
Total Assets 0n/a
Accounts Payable 0n/a
Current Debt 0n/a
Total Current Liabilities 0n/a
Long-Term Debt 0n/a
Total Liabilities 0n/a
Total Equity 0n/a
Cash Flow
Depreciation & Amortisation 0n/a
Change in Working Capital 0n/a
Operating Cash Flow 0n/a
Net Change in PP&E and Intangibles 0n/a
Investing Cash Flow 0n/a
Dividends Paid 0n/a
Financing Cash Flow 0n/a
Total Change in Cash 0n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 0.0%n/a
Operating Margin 0.0%n/a
Net Profit Margin 0.0%n/a
Return on Equity 0.0%n/a
Return on Assets 0.0%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales n/a
Book to Market Value n/a
Other Ratios
Current Ratio 0.0%n/a
Liabilities to Equity Ratio 0.0%n/a
Debt to Assets Ratio 0.0%n/a
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reasons:
- It is not known how cost items are reported in the original P&L
- Not all line items from the original statement have been associated with a standardised figure (21 items missing)
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net sales
795
858
918
995
1,378
1,602
1,708
1,761
Cost of sales (exclusive of items shown separately below)
674
754
799
-870
1,234
1,406
1,460
1,527
AR1 research and development (see Note 1(r))
0
0
0
0
0
0
32
0
Selling, general and administrative
10
27
41
-42
54
38
49
54
Depreciation and amortization
26
28
25
-22
44
64
65
65
Executive severance agreements
3
0
0
0
0
0
0
0
Loss on bank amendment
0
0
0
0
0
0
0
0
Loss on debt
0
0
0
0
5
61
2
35
Legal settlement
1
0
0
0
0
0
50
0
Other
3
12
15
26
29
14
17
20
Total operating costs and expenses
717
820
879
960
1,365
1,583
1,675
1,700
Operating (loss) income
78
38
39
35
13
20
33
61
Interest income
-2
-2
-1
-1
0
0
0
-1
Interest expense
39
37
31
22
49
53
50
33
Total non-operating expense, net
37
35
30
22
49
53
50
32
(Loss) income from continuing operations before income taxes
41
2
9
13
-36
-33
-17
29
Income tax provision
-18
-4
6
19
-198
16
0
11
(Loss) income from continuing operations
59
6
3
-6
163
-49
-17
18
(Loss) income from discontinued operations, net of income taxes
-7
1
0
3
0
-1
1
0
Net Income (Loss)
52
7
3
-3
163
-50
-16
18
Remarks
restated on Feb 7, 2012 n/a
calculated values,
restated on Feb 12, 2013 n/a
calculated values,
restated on Feb 7, 2014 n/a
calculated values,
restated on Jan 30, 2015 n/a
calculated values,
restated on Feb 16, 2016 n/a
calculated values,
restated on Mar 1, 2017 n/a
calculated values,
restated on Mar 1, 2017 n/a
calculated values,
restated on Mar 1, 2017 n/a
calculated values,
Balance SheetBS data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (56 items missing)
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash and cash equivalents
n/a
182
188
162
198
266
209
410
Marketable securities
n/a
27
0
0
0
0
0
0
Accounts receivable
n/a
107
107
112
214
171
170
136
Inventories
n/a
51
50
47
106
138
156
185
Grantor trust
n/a
2
0
0
0
0
0
0
Recoverable from the U.S. government and other third parties for environmental remediation costs
n/a
32
24
22
20
19
24
25
Receivable from Northrop Grumman Corporation (“Northrop”)
n/a
0
6
6
6
0
6
6
Other current assets, net
n/a
25
22
17
22
39
69
92
Income taxes
n/a
8
5
3
13
2
0
0
Deferred income taxes
n/a
0
0
0
17
20
0
0
Total current assets
n/a
433
401
368
596
660
633
855
Property, plant and equipment, net
n/a
126
127
144
375
367
363
366
Grantor trust
n/a
15
0
0
0
0
0
0
Real estate held for entitlement and leasing
n/a
60
63
70
80
94
86
92
Recoverable from the U.S. government and other third parties for environmental remediation costs
n/a
141
114
108
89
87
207
240
Receivable from Northrop
n/a
0
66
69
72
0
63
62
Deferred income taxes
n/a
0
0
0
176
261
325
293
Goodwill
n/a
95
95
95
160
158
158
158
Intangible assets
n/a
17
15
14
136
122
108
94
Income taxes
n/a
0
0
0
0
7
0
0
Other noncurrent assets, net
n/a
106
58
51
73
93
82
90
Total noncurrent assets
n/a
559
539
551
1,159
1,258
1,392
1,395
Total assets
n/a
992
940
919
1,755
1,919
2,026
2,250
Liabilities and owners' equity
Short-term borrowings and current portion of long-term debt
n/a
66 66000000
3 2800000
3 2700000
3 2900000
5 5300000
5 5300000
56 55600000
Accounts payable
n/a
27 27100000
34 33800000
56 56100000
123 122500000
104 104000000
64 64200000
96 96200000
Reserves for environmental remediation costs
n/a
41 40700000
41 40700000
40 39500000
37 36600000
32 31900000
33 32600000
37 37100000
Postretirement medical and life insurance benefits
n/a
7 7100000
7 6800000
8 7500000
7 7300000
6 6400000
6 6000000
5 5200000
Advance payments on contracts
n/a
110 110000000
109 108500000
100 100100000
104 104400000
197 197400000
231 230900000
222 221800000
Deferred income taxes
n/a
0 0
3 3100000
9 9400000
0 0
0 0
0 0
0 0
Other current liabilities
n/a
110 110300000
104 104100000
103 103300000
206 206000000
221 221400000
203 203100000
168 167800000
Total current liabilities
n/a
361 361200000
300 299800000
319 318600000
480 479700000
566 566400000
542 542100000
584 583700000
Second-priority senior notes
n/a
75 75000000
75 75000000
0 0
460 460000000
460 460000000
0 0
0 0
Convertible subordinated notes
n/a
200 200000000
200 200200000
200 200200000
193 193200000
134 133800000
0 0
0 0
Other debt
n/a
1 1100000
1 900000
1 800000
1 600000
89 89300000
0 0
0 0
Deferred income taxes
n/a
8 7600000
5 4500000
2 2200000
0 0
0 0
0 0
0 0
Long-term debt
n/a
51 50600000
48 47500000
45 45000000
43 42500000
94 93800000
634 633700000
608 608000000
Reserves for environmental remediation costs
n/a
177 177000000
150 149900000
150 150000000
135 134700000
134 134100000
270 269700000
313 312600000
Pension benefits
n/a
176 175500000
236 236400000
455 454500000
262 261700000
483 482800000
581 580600000
548 548200000
Postretirement medical and life insurance benefits
n/a
72 71800000
68 68400000
68 68300000
59 59300000
52 51700000
45 44800000
37 37400000
Other noncurrent liabilities
n/a
67 66800000
64 64100000
69 68500000
74 73800000
81 80600000
95 95200000
124 124000000
Total Noncurrent Liabilities
n/a
825 825400000
847 846900000
990 989500000
1,226 1225800000
1,526 1526100000
1,624 1624000000
1,630 1630200000
Total liabilities
n/a
1,187 1186600000
1,147 1146700000
1,308 1308100000
1,706 1705500000
2,093 2092500000
2,166 2166100000
2,214 2213900000
Commitments and contingencies (Note 7)
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Redeemable common stock
n/a
5 5100000
4 4400000
4 3900000
0 200000
2 1600000
2 1600000
1 1100000
Preference stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Common stock
n/a
6 5900000
6 5900000
6 5900000
6 5900000
6 5900000
7 6500000
7 6900000
Other capital
n/a
257 257300000
261 261200000
270 269600000
280 280100000
287 287400000
343 342600000
457 456900000
Treasury stock at cost
n/a
0 0
0 0
0 0
0 0
-65 -64500000
-65 -64500000
-65 -64500000
Accumulated deficit
n/a
-182 -182200000
-179 -179300000
-182 -181900000
-14 -14000000
-71 -70600000
-80 -79800000
-62 -61800000
Accumulated other comprehensive loss, net of income taxes
n/a
-281 -281200000
-299 -299400000
-486 -486300000
-222 -222400000
-334 -333700000
-347 -347000000
-303 -303000000
Total stockholders’ equity (deficit)
n/a
-200 -200200000
-212 -211600000
-393 -392700000
50 49600000
-176 -175500000
-142 -142200000
35 34500000
Total liabilities, redeemable common stock, and stockholders’ (deficit) equity
n/a
992 991500000
940 939500000
919 919300000
1,755 1755300000
1,919 1918600000
2,026 2025500000
2,250 2249500000
Remarks restated on n/a restated on Feb 7, 2012 n/a restated on Feb 12, 2013 n/a restated on Feb 7, 2014 n/a restated on Jan 30, 2015 n/a restated on Feb 16, 2016 n/a restated on Mar 1, 2017 n/a restated on Aug 3, 2017 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (56 items missing)
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income (Loss)
52
7
3
-3
163
-50
-16
18
Loss (income) from discontinued operations, net of income taxes
7
-1
0
-3
0
1
-1
0
Depreciation and amortization
26
28
25
22
44
64
65
65
Amortization of debt discount and financing costs
13
11
7
3
5
4
3
2
Stock-based compensation
3
0
4
7
14
6
9
13
Retirement benefits, net
0
42
46
41
65
31
63
32
Savings plan expense, non-cash
2
0
0
0
0
0
0
0
Net recognized gain on marketable securities
0
0
0
0
0
0
0
0
Impairment of long-lived asset
0
2
0
0
0
0
0
0
Loss on debt repurchased
0
1
0
0
5
61
2
34
Loss on bank amendment
0
0
0
0
0
0
0
0
Loss on disposal of long-lived assets
0
0
0
0
0
3
1
1
Gain on sale of technology
0
0
0
0
0
-7
-1
0
Tax benefit on stock-based awards
0
0
0
-3
0
-1
-3
0
Loss on bank amendment
0
1
1
0
0
0
0
0
Accounts receivable
-19
10
0
-5
-24
29
-1
33
Inventories
9
11
2
3
-26
-32
-20
-29
Grantor trust
11
0
0
0
0
0
0
0
Other current assets, net
0
7
2
1
-4
-7
-26
-23
Income tax receivable
8
-5
2
7
-12
0
0
0
Real estate held for entitlement and leasing
-6
-5
-4
-4
-4
-15
-8
-6
Receivable from Northrop
0
-5
-8
-3
3
-3
6
1
Recoverable from the U.S. government and other third parties for environmental remediation costs
0
3
29
8
15
9
-128
-34
OTHER NONCURRENT ASSETS
10
7
3
3
-2
-24
12
-8
Accounts payable
-14
9
7
22
50
-18
-5
27
Pension benefits
-29
0
-3
0
0
0
0
0
Retirement benefits
-11
-6
-6
-5
-5
0
0
0
Advance payments on contracts
19
44
-2
-8
-48
97
6
-9
Other current liabilities
-18
2
-2
5
58
20
-18
-38
Deferred income taxes
1
-2
0
4
-200
-7
-28
5
Reserves for environmental remediation costs
0
-5
-27
-1
-18
-5
140
47
Other noncurrent liabilities and other
-12
-3
-2
-1
1
0
12
26
Net cash provided by (used in) continuing operations
52
149
77
88
78
153
65
158
Net cash used in discontinued operations
-1
-1
0
-2
0
-2
0
0
Net cash provided by (used in) operating activities
50
148
77
86
77
151
65
158
Purchases of restricted cash investments
0
-195
0
0
-470
0
0
0
Sale of restricted cash investments
0
195
0
0
470
0
0
0
Purchases of investments
0
0
0
0
-1
0
0
0
Purchase of Rocketdyne Business
0
0
0
0
-411
0
0
0
Proceeds from sale of technology
0
0
0
0
0
8
1
1
Proceeds from sale of land
0
0
0
1
0
0
0
0
Purchases of marketable securities
0
-154
-15
0
0
0
0
0
Sales of marketable securities
0
128
42
0
0
0
0
0
Capital expenditures
-14
-17
-21
-37
-63
-43
-37
-48
Net cash used in investing activities
-14
-44
6
-37
-475
-36
-36
-47
Proceeds from issuance of debt
0
200
0
0
460
189
0
800
Debt issuance costs including equity component of convertible debt
0
-8
-4
-1
-15
-4
0
-10
Debt repayments/repurchases
-2
-240
-70
-79
-13
-166
-81
-701
Proceeds from shares issued under equity plans, net
0
0
0
1
1
0
1
4
Repurchase of shares for option cost and to satisfy tax withholding obligations
0
0
0
0
0
-2
-7
-4
Purchase of treasury stock
0
0
0
0
0
-65
0
0
Tax benefit on stock-based awards
0
0
0
3
0
1
3
0
Vendor financing repayments
0
-2
-2
0
0
0
0
0
Net cash provided by (used in) financing activities
-2
-49
-76
-76
433
-47
-84
91
Net increase (decrease) in cash and cash equivalents
34
55
7
-26
36
68
-55
202
Remarks
restated on Feb 7, 2012 n/a
calculated values,
restated on Feb 12, 2013 n/a
calculated values,
restated on Feb 7, 2014 n/a
calculated values,
restated on Jan 30, 2015 n/a
calculated values,
restated on Feb 16, 2016 n/a
calculated values,
restated on Mar 1, 2017 n/a
calculated values,
restated on Mar 1, 2017 n/a
calculated values,
restated on Mar 1, 2017 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo